Visa signs $2.4 billion deal to acquire Israeli anti-fraud firm BioCatch

Visa has signed a definitive agreement to acquire Israeli anti-fraud company BioCatch for $2.4 billion in cash. BioCatch, based in Tel Aviv, provides AI and machine-learning systems to over 350 financial institutions in 21 countries, protecting 760 million users by analyzing anonymized data points to identify suspicious activity. This acquisition aims to enhance Visa's cybersecurity and risk-management solutions, addressing the growing challenge of account takeovers and scams. Andrew Torre, president of value-added services at Visa, stated, "BioCatch will help our clients stop fraud before it reaches the point of payment." The transaction is expected to close by the end of Visa's fiscal second quarter of 2027, pending regulatory approvals.